16:18 EDT Kiora Pharmaceuticals (KPRX) files $100M mixed securities shelf
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KPRX:
- Kiora Pharmaceuticals Highlights at Ophthalmology Conference
- Promising Developments and Strategic Partnerships Drive Buy Rating for Kiora Pharmaceuticals
- Kiora Pharmaceuticals Advances Retinal Disease Pipeline
- Positive Outlook for Kiora Pharmaceuticals: Buy Rating Affirmed Amid Promising Developments and Strategic Initiatives
- Kiora Pharmaceuticals granted new patent for KIO-104, says H.C. Wainwright